STOCK TITAN

Egain Corp SEC Filings

EGAN Nasdaq

Welcome to our dedicated page for Egain SEC filings (Ticker: EGAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Subscription revenue deferrals, multi-year contracts, and rapidly evolving AI disclosures make eGain’s SEC documents anything but light reading. If tracking cloud ARR trends or spotting when executives file eGain insider trading Form 4 transactions feels overwhelming, you’re not alone.

Stock Titan solves the problem in seconds. Our platform ingests every eGain quarterly earnings report 10-Q filing, 8-K flash note, and full 10-K, then deploys AI to highlight what matters—SaaS revenue recognition choices, R&D capitalization for conversational AI, and shifts in international billings. Interactive dashboards offer eGain Form 4 insider transactions real-time, while concise summaries turn footnotes into plain English for investors who simply want eGain SEC filings explained simply.

Wondering how the new AI module impacts margins? The “Earnings” view links straight to the line items our algorithm flags as significant so you can conduct rapid eGain earnings report filing analysis. Need to monitor leadership activity? One click surfaces eGain executive stock transactions Form 4. Curious about compensation or voting matters? The proxy section demystifies every eGain proxy statement executive compensation table.

  • Real-time EDGAR feeds with instant alerts on eGain 8-K material events explained
  • AI-powered summaries that make the eGain annual report 10-K simplified
  • Exportable data for ARR, churn, segment revenue, and more
  • Historical archive so you can understanding eGain SEC documents with AI across multiple years

From first-time shareholders to seasoned analysts, get the clarity you need—no PDF spelunking required.

Rhea-AI Summary

eGain Corporation reported stronger quarterly results for the three months ended September 30, 2025. Total revenue was $23.5 million, up 8% year over year, led by SaaS revenue of $21.9 million (93% of total), while professional services declined to $1.6 million. Gross margin expanded to 75% as cost of revenue fell.

Income from operations rose to $2.8 million (12% margin) from $0.5 million (2% margin) a year ago. Net income was $2.8 million, or $0.10 per diluted share. Cash and cash equivalents were $70.9 million and total deferred revenue was $47.4 million. Remaining performance obligations were $86.9 million, with $58.4 million expected within one year. The company repurchased 230,734 shares for $1.5 million, with $19.7 million remaining under its authorization. eGain issued a fully vested warrant for 500,000 shares at an exercise price of $7.10, recognizing $1.35 million of non-cash expense.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

eGain (EGAN) insider activity: the Chief Financial Officer reported Form 4 transactions on 11/03/2025. He exercised 5,000 stock options at $2.5 and sold 5,000 common shares at an average price of $14.44 pursuant to a Rule 10b5-1 plan adopted on March 8, 2024.

After these trades, he directly holds 129,187 common shares and 38,000 stock options remain beneficially owned. The reported sales were executed across multiple trades between $14.23 and $14.74.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

eGain (EGAN) reported an insider transaction by director Phiroz P. Darukhanavala. On 10/28/2025, he exercised stock options (transaction code M) for 500 shares of common stock at $4.335 per share. Following the transaction, he beneficially owns 3,000 shares directly.

The exercised option covered 500 underlying shares and now shows 0 derivative securities remaining. The option was fully vested on 11/06/2016 and carried an expiration date of 11/06/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

eGain (EGAN) director reported an option exercise. On 10/24/2025, the reporting person exercised stock options and acquired 500 shares of Common Stock at $4.335 per share (Transaction Code M). Following the transaction, direct beneficial ownership stood at 819,795 shares. The exercised options represented the right to buy 500 shares and, after the transaction, 0 derivative securities remained. The options became fully vested on November 6, 2016.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Summary

eGain Corporation filed its Definitive Proxy Statement for the 2025 Annual Meeting, to be held on December 9, 2025 at 1:00 p.m. PT in Sunnyvale, CA.

Stockholders will vote on: (1) election of four directors (Ashutosh Roy, Gunjan Sinha, Phiroz P. Darukhanavala, and Brett Shockley), (2) a non-binding advisory vote on executive compensation, and (3) ratification of BPM LLP as the independent registered public accounting firm for the year ending June 30, 2026. The Board recommends voting “FOR” all proposals.

The record date is October 13, 2025, with 27,019,335 shares of common stock outstanding as of that date. The proxy details board leadership and committee changes, director and executive compensation (including stock option awards), major beneficial owners, and governance policies, including cybersecurity oversight, a clawback policy effective October 2, 2023, and the Company’s insider trading policy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

This Amendment No. 4 to a Schedule 13D reports that a group led by Kanen Wealth Management and David L. Kanen beneficially owns a combined 2,047,683 shares of EGAIN Corp common stock, representing approximately 7.6% of the 26,867,067 shares outstanding. Ownership breaks down as 1,056,031 shares (Philotimo Fund, 3.9%), 734,187 shares (Philotimo Focused Growth & Income Fund, 2.7%), and 22,429 shares directly held by Mr. Kanen; Kanen Wealth Management is reported as investment manager/GP for the pooled positions.

The filing discloses aggregate purchase prices for disclosed holdings: $7,977,132 for Philotimo, $5,934,578 for PHLOX, $1,880,148 for Managed Accounts, and $197,419 for Mr. Kanen. Transactions for Philotimo during the past 60 days are included as an exhibit; PHLOX, KWM and Mr. Kanen report no transactions in the past 60 days. The statement clarifies group status under Section 13(d)(3) and is signed by David L. Kanen.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

EGAIN Corp Schedule 13D Amendment No. 4 discloses that a group led by David L. Kanen now beneficially owns 2,047,683 common shares, representing approximately 7.6% of the 26,867,067 shares outstanding referenced in the filing. The ownership is held across four reporting persons: Philotimo Fund, LP (1,056,031 shares, ~3.9%), Philotimo Focused Growth & Income Fund (PHLOX) (734,187 shares, ~2.7%), certain Managed Accounts (157,918 shares), and Mr. Kanen directly (22,429 shares).

The filing states the purchases were made in open-market transactions using working capital or customers' funds and reports aggregate purchase prices: $7,977,132 for Philotimo's shares, $5,934,578 for PHLOX's shares, $1,880,148 for Managed Accounts, and $197,419 for Mr. Kanen's direct holdings. The Schedule confirms the reporting persons are a Section 13(d)(3) group and details voting and dispositive powers, including shared voting/dispositive power over 2,025,254 shares by Kanen Wealth Management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Eric Smit, Chief Financial Officer of EGAIN Corp (EGAN), reported multiple stock and option transactions on 10/03/2025 under a Rule 10b5-1 plan adopted on 3/08/2024. The filing shows three non-derivative purchases totaling $37,500 (15,000 shares at $2.5 each) and three non-derivative sales totaling $150,000 (15,000 shares at $10 each). Parallel option-related entries record three grants/exercises for 5,000 employee stock options each (totaling 15,000 options) with an exercise price of $2.5, exercisable since 09/19/2017 and fully vested. The transactions changed reported common stock holdings in stages, with the last reported direct common share ownership at 129,187 shares and derivative holdings reflecting 43,000, 48,000, and 53,000 underlying shares in separate option lines.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Egain (EGAN)?

The current stock price of Egain (EGAN) is $10.2 as of December 29, 2025.

What is the market cap of Egain (EGAN)?

The market cap of Egain (EGAN) is approximately 283.5M.
Egain Corp

Nasdaq:EGAN

EGAN Rankings

EGAN Stock Data

283.50M
15.95M
36.68%
55.26%
1.45%
Software - Application
Services-prepackaged Software
Link
United States
SUNNYVALE